Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.6.2699

Impact of AhR, CYP1A1 and GSTM1 Genetic Polymorphisms on TP53 R273G Mutations in Individuals Exposed to Polycyclic Aromatic Hydrocarbons  

Gao, Meili (Institute of Mitochondrial Biology and Medicine, Department of Biological Science and Engineering, The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University)
Li, Yongfei (School of Materials and Chemical Engineering, Xi'an Technological University)
Xue, Xiaochang (State Key Laboratory of Cancer Biology, Department of Biopharmaceutics School of Pharmacy, Fourth Military Medical University)
Long, Jiangang (Institute of Mitochondrial Biology and Medicine, Department of Biological Science and Engineering, The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University)
Chen, Lan (Center of Shared Experimental Facilities, The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University)
Shah, Walayat (Institute of Basic Medical Sciences, Khyber Medical University)
Kong, Yu (Institute of Mitochondrial Biology and Medicine, Department of Biological Science and Engineering, The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.6, 2014 , pp. 2699-2705 More about this Journal
Abstract
This study was to undertaken to investigate the impacts of AhR, CYP1A1, GSTM1 genetic polymorphisms on the R273G mutation in exon 8 of the tumor suppressor p53 gene (TP53) among polycyclic aromatic hydrocarbons (PAHs) exposed to coke-oven workers. One hundred thirteen workers exposed to PAH and 82 control workers were recruited. We genotyped for polymorphisms in the AhR, CYP1A1, GSTM1, and TP53 R273G mutation in blood by PCR methods, and determined the levels of 1-hydroxypyrene as PAH exposure marker in urine using the high pressure liquid chromatography assay. We found that the distribution of alcohol users and the urinary excretion of 1-OHP in the exposed workers were significantly higher than that of the control workers (p=0.004, p<0.001, respectively). Significant differences were observed in the p53 genotype distributions of smoking subjects (p=0.01, 95%CI: 1.23-6.01) and PAH exposure (p=0.008, 95%CI: 1.24-4.48), respectively. Further, significant differences were observed in the p53 exon 8 mutations for the genetic polymorphisms of Lys/Arg for AhR (p=0.02, 95%CI: 0.70-15.86), Val/Val for CYP1A1 (p=0.04, 95%CI: 0.98-19.09) and null for GSTM1 (p=0.02, 95%CI: 1.19-6.26), respectively. Our findings indicated that polymorphisms of PAH metabolic genes, such as AhR, CYP1A1, GSTM1 polymorphisms may interact with p53 genetic variants and may contribute to PAH related cancers.
Keywords
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Yao R, Wang Y, D'Agostini F, et al (2005). K-ras mutations in lung tumors from p53 mutant mice exposed to cigarette smoke. Exp Lung Res, 31, 271-81.   DOI   ScienceOn
2 van Delft JH, Steenwinkel MS, van Asten JG, et al (2001). Biological monitoring the exposure to polycyclic aromatic hydrocarbons of coke oven workers in relation to smoking and genetic polymorphisms for GSTM1 and GSTT1. Ann Occup Hyg, 45, 395-408.   DOI
3 Wiencke JK, Pemble S, Ketterer B, et al (1995). Gene deletion of glutathione s-transferase theta: correlation with induced genetic damage and potential role in endogenous mutagenesis. Cancer Epidemiol Biomarkers Prev, 4, 253-9.
4 Yang AL, Smith AG, Akhtar R, et al (1999). Low levels of p53 are associated with resistance to tetrachlorodibenzo-p-dioxin toxicity in DBA/2 mice. Pharmacogenetics, 9, 183-8.
5 Zhang DS, Lin GF, Ma QW, et al (2002). Nonassociation of aryl hydrocarbon receptor genotypes with susceptibility to bladder cancer in Shanghai population. Acta Pharmacol Sin, 23, 188-92.
6 Zhong S, Wyllie AH, Barnes D, et al (1993). Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis, 14, 1821-4.   DOI   ScienceOn
7 Smart J, Daly AK (2000). Variation in induced CYP1A1 levels: relationship to CYP1A1, Ah receptor and GSTM1 polymorphisms. Pharmacogenetics, 10, 11-24.   DOI   ScienceOn
8 Shimada T, Fujii-Kuriyama Y (2004). Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1. Cancer Sci, 95, 1-6.   DOI   ScienceOn
9 Shimizu Y, Nakatsuru Y, Ichinose M, et al (2000). Benzo[a] pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proc Natl Acad Sci USA, 97, 779-82.   DOI
10 Siwinska E, Mielzynska D, Kapka L (2004). Association between urinary 1-hydroxypyrene and genotoxic effects in coke oven workers. Occup Environ Med, 61, 10.   DOI
11 Smith LE, Denissenko MF, Bennett WP, et al (2000). Targeting of lung cancer mutational hotspots by polycyclic aromatic hydrocarbons. J Natl Cancer Inst, 92, 803-11.   DOI   ScienceOn
12 Strickland PT, Kang D, Bowman ED, et al (1994). Identification of 1-hydroxypyrene glucuronide as a major metabolite in human urine by synchronous fluorescence spectroscopy and gas chromatography-mass spectrometry. Carcinogenesis, 15, 483-7.   DOI   ScienceOn
13 Ramadoss P, Marcus C, Perdew GH (2005). Role of the aryl hydro-carbon receptor in drug metabolism. Expert Opin Drug Metab Toxicol, 1, 9-21.   DOI   ScienceOn
14 Rusin M, Butkiewicz D, Malusecka E, et al (1999). Molecular epidemiological study of non-small-cell lung cancer from an environmentally polluted region of Poland. Br J Cancer, 80, 1445-52.   DOI   ScienceOn
15 Sram RJ, Binkova B (2000). Molecular epidemiology studies on occupational and environmental exposure to mutagens and carcinogens, 1997-1999. Environ Health Perspect, 108, 57-70.   DOI
16 Nakatsuru Y, Wakabayashi K, Fujii-Kuriyama Y, et al (2004). Dibenzo (A,L) pyrene-induced genotoxic and carcinogenic responses are dramatically suppressed in aryl hydrocarbon receptor-deficient mice. Int J Cancer, 112, 179-83.   DOI   ScienceOn
17 Maier A, Micka J, Miller K, et al (1998). Aromatic hydrocarbon receptor polymorphism: development of new methods to correlate genotype with phenotype. Environ Health Perspect, 106, 421-6.   DOI
18 Marczynski B, Rihs HP, Rossbach B, et al (2002). Analysis of 8-oxo-7,8-dihydro-2 -deoxyguanosine and DNA strand breaks in white blood cells of occupationally exposed workers: comparison with ambient monitoring, urinary metabolites and enzyme polymorphisms. Carcinogenesis, 23, 273-81.   DOI   ScienceOn
19 Moretti M, Dell'Omo M, Villarini M, et al (2007). Primary DNA damage and genetic polymorphisms for CYP1A1, EPHX and GSTM1 in workers at a graphite electrode manufacturing plant. BMC Public Health, 7, 270.   DOI
20 Nerurkar PV, Okinaka L, Aoki C, et al (2000). CYP1A1, GSTM1, and GSTP1 genetic polymorphisms and urinary 1-hydroxypyrene excretion in non-occupationally exposed individuals. Cancer Epidemiol Biomarkers Prev, 9, 1119-22.
21 Ovrebo S, Ryberg D, Haugen A, et al (1998). Glutathione S-transferase M1 and P1 genotypes and urinary excretion of 1-hydroxypyrene in coke oven workers. Sci Total Environ, 220, 25-31.   DOI   ScienceOn
22 Park JH, Gelhaus S, Vedantam S, et al (2008). The pattern of p53 mutations caused by PAH o-quinones is driven by 8-oxo-dGuo formation while the spectrum of mutations is determined by biological selection for dominance. Chem Res Toxicol, 21,1039-49.   DOI   ScienceOn
23 Przygodzki RM, Bennett WP, Guinee MD, et al (1998). p53 mutation spectrum in relation to GSTM1, CYP1A1 and CYP2E1 in surgically treated patients with non-small cell lung cancer. Pharmacogenetics, 8, 503-11.   DOI
24 Jongeneelen FJ, Anzion RBM (1990). Analyses of hazardous substances in biological materials. Deutsche Forschungsgemeinschaft, 3, 151-69.
25 Hussain SP, Amstad P, Raja K, et al (2001). Mutability of p53 hotspot codons to benzo (a) pyrene diol epoxide (BPDE) and the frequency of p53 mutations in nontumorous human lung. Cancer Res, 61, 6350-5.
26 Gu A, Ji G, Jiang T, et al (2012). Contributions of aryl hydrocarbon receptor genetic variants to the risk of glioma and PAH-DNA adducts. Toxicol Sci, 128, 357-64.   DOI   ScienceOn
27 Jiang H, Shen YM, Quinn AM, et al (2005). Competingroles of cytochrome P450 1A1/1B1 and aldo-keto reductase 1A1 in the metabolic activation of (+/-)-7, 8-dihydroxy-7,8-dihydrobenzo[ a]pyrene in human bronchoal-veolar cell extracts. Chem Res Toxicol, 18, 365-74.   DOI   ScienceOn
28 Kawajiri K, Watanabe J, Eguchi H, et al (1995). Polymorphisms of human Ah receptor gene are not involved in lung cancer. Pharmacogenetics, 5, 151-8.   DOI
29 Hsieh LL, Wang PF, Chen IH, et al (2001). Characteristics of mutations in the p53 gene in oral squamous cell carcinoma associated with betel quid chewing and cigarette smoking in Taiwanese. Carcinogenesis, 22, 1497-503.   DOI   ScienceOn
30 Kawajiri K, Eguchi H, Nakachi K, et al (1996). Association of CYP1A1germ line polymorphisms with mutations of the p53 gene in lung cancer. Cancer Res, 56, 72-6.
31 Lai TJ, Tsai YY, Cheng YW, et al (2006). An association between BPDE-like DNA adduct levels and p53 gene mutation in pterygium. Mol Vis, 12, 1687-91.
32 Lazarus P, Stern J, Zwiebel N, et al (1996). Relationship between p53 mutation incidence in oral cavity squamous cell carcinomas and patient tobacco use. Carcinogenesis, 17, 733-9   DOI   ScienceOn
33 Chen B, HuY, Jin T, et al (2007). The influence of metabolic gene polymorphis ms on urinary 1-hydroxypyrene concentration s in Chinese coke oven workers. Sci Total Environ, 381, 38-46.   DOI   ScienceOn
34 Celius T, Matthews J (2010). Functional analysis of six human aryl hydrocarbon receptor variants in human breast cancer and mouse hepatoma cell lines. Toxicology, 277, 59-65.   DOI   ScienceOn
35 Chen Y, Bai Y, Yuan J, et al (2006). Associationof polymorphisms in AhR, CYP1A1, GSTM1, and GSTT1 genes with levels of DNA damage in peripheral blood lymphocytes among coke-oven workers. Cancer Epidemiol Biomarkers Prev 15, 1703-07.   DOI   ScienceOn
36 Denissenko MF, Pao A, Tang M, et al (1996). Preferential formation of benzo (a) pyrene adducts at lung cancer mutational hotspots in P53. Science, 274, 430-2.   DOI   ScienceOn
37 Giri SK, Yadav A, Kumar A, et al (2012). CYP1A1 gene polymorphisms: modulator of genetic damage in coal-tar workers. Asian Pac J Cancer Prev, 13, 3409-16.   DOI   ScienceOn
38 Eaton DL, Bammler TK (1999). Concise review of the glutathione s-transferases and their significance to toxicology. Toxicol Sci, 49, 156-64.   DOI   ScienceOn
39 Gao M, Li Y, Sun YL, et al (2011). A common carcinogen benzo[a]pyrene causes p53 overexpression in mouse cervix via DNA damage. Mutat Res, 724, 69-75.   DOI   ScienceOn
40 Garritano S, Inga A, Gemignani F, et al (2013). More targets, more pathways and more clues for mutant p53. Oncogenesis, 2, 54.   DOI   ScienceOn
41 Gonzalez R, Silva JM, Sanchez A, et al (2000). Microsatellite alterations and TP53 mutations in plasma DNA of smallcell lung cancer patients: followup study and prognostic significance. Oncology, 11, 1097-104.
42 Alexandrie AK, Warholm M, Carstensen U, et al (2000). CYP1A1 and GSTM1 polymorphisms affect urinary 1-hydroxypyrene levels after PAH exposure. Carcinogenesis, 21, 669-76.   DOI   ScienceOn
43 Bartsch H, Nair U, Risch A, et al (2000). Genetic polymorphism of CYP genes, alone or in combination as a risk modifier of tobacco related cancers. Cancer Epidemiol Biomark Prev, 9, 3-28.
44 Baselt RC (1980). Biological monitoring methods for industrial chemicals. Davis, CA: Biomedical Publications, 207-11.
45 Bin P, Leng S, Cheng J, et al (2008). Association of aryl hydrocarbon receptor gene polymorphisms and urinary 1-hydroxypyrene in polycyclic aromatic hydrocarbonexposed workers. Cancer Epidemiol Biomarkers Prev, 17, 1702-08.   DOI   ScienceOn
46 Cavalieri EL, Rogan EG (1995). Central role of radical cations in metabolic activation of polycyclic aromatic hydrocarbons. Xenobiotica, 25, 677-88.   DOI   ScienceOn
47 Board P, Coggan M, Johnston P, et al (1990). Genetic heterogeneity of the human glutathione transferases: a complex of gene families. Pharmacol Ther, 48, 357-69.   DOI   ScienceOn
48 Bufalo NE, Leite JL, Guilhen AC, et al (2006). Assumpcao and laura s ward. Smoking and susceptibility to thyroid cancer: an inverse association with CYP1A1 allelic variants. Endocr Relat Cancer, 13, 1185-93.   DOI   ScienceOn
49 Castano-Vinyals G, D'Errico A, Malats N, et al (2004). Biomarkers of exposure to polycyclic aromatic hydrocarbons from environmental air pollution. Occup Environ Med, 61,12.   DOI